Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (XTNT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
xtnt · stock forecast · 5 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$1.50
Consensus
$1.50
+234.4% upside
Low
$1.50
Median: $1.5 · Last Close: $0.45
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.44 | ↓ 1.88% |
1-day model range: $0.44–$0.44. Peak: $0.44 (-1.88%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $0 | -39.3% |
| 2028 | $0 | -51.2% |
| 2029 | $0 | -56.0% |
| 2030 | $0 | -58.2% |
| 2031 | — | -59.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · XTNT · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | BTIG | Maintains | Buy→Buy |
| 2026-03-31 | BTIG | Maintains | Buy→Buy |
| 2025-11-11 | BTIG | Maintains | Buy→Buy |
| 2024-05-16 | BTIG | Maintains | Buy→Buy |
| 2023-07-11 | Craig-Hallum | Maintains | Buy→Buy |
| 2023-04-26 | Craig-Hallum | Maintains | Buy→Buy |
| 2019-05-17 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2016-12-08 | Maxim Group | Maintains | Buy→Buy |
| 2016-11-30 | Aegis Capital | Maintains | Buy→Buy |
| 2015-10-23 | Brean Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Xtant Medical Holdings, Inc. (XTNT) stock. Of the recent 10 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover XTNT.
Analyst Recommendation Trends
XTNT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$102M
↓ 16.9% YoY
Revenue Next Year
$112M
↑ 9.4% YoY
EPS This Year
$0.01
EPS Next Year
$-0.00
↓ 106.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast XTNT EPS of $0.01 for the current fiscal year, based on estimates from 2 analysts. The XTNT revenue forecast is $102M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The XTNT stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus XTNT price target is $1.50 (+234.4% upside), with an analyst consensus of Buy.
The XTNT short-term stock prediction for tomorrow is $0.44 (-1.88%). The XTNT stock price prediction for 2027 estimates an average of $0. The XTNT stock prediction for 2030 projects a range of $0–$0.
Xtant Medical Holdings, Inc. trades on AMEX under the ticker XTNT. The XTNT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 80% of covering analysts.
Frequently asked questions
XTNT forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month XTNT price target is $1.50, with a high forecast of $1.50 and a low of $1.50. The median price target is shown in the chart above when available. This implies +234.4% potential upside from the current price of $0.45.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.